- Phenylketonuria (PKU) program on track for Phase 3 trial initiation in first half of 2023 – - Recent milestones include receipt of Rare Pediatric and.
Synlogic Reports First Quarter 2023 Financial Results and Provides Business Update streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Relief Therapeutics Holding SA / Key word(s): Annual Results Relief Therapeutics Announces Full Year 2022 Financial Results and Provides Corporate Update 14-Apr-2023 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsible for the content of this.
Relief Therapeutics Holding SA / Key word(s): Annual Results Relief Therapeutics Announces Full Year 2022 Financial Results and Provides Corporate Update 14-Apr-2023 / 07:00 CET/CEST Release of an